Biosafety considerations for autopsy.Am J Forensic Med Pathol. 2002 Jun; 23(2):107-22.AJ
Abstract
An autopsy may subject prosectors and others to a wide variety of infectious agents, including bloodborne and aerosolized pathogens such as human immunodeficiency virus, hepatitis B and C viruses, and Mycobacterium tuberculosis. Other hazards include toxic chemicals (e.g., formalin, cyanide, and organophosphates) and radiation from radionuclides used for patient therapy and diagnosis. These risks can be substantially mitigated through proper assessment, personal protective equipment, appropriate autopsy procedures, and facility design.
Links
MeSH
Pub Type(s)
Journal Article
Review
Language
eng
PubMed ID
12040252
Citation
Nolte, Kurt B., et al. "Biosafety Considerations for Autopsy." The American Journal of Forensic Medicine and Pathology, vol. 23, no. 2, 2002, pp. 107-22.
Nolte KB, Taylor DG, Richmond JY. Biosafety considerations for autopsy. Am J Forensic Med Pathol. 2002;23(2):107-22.
Nolte, K. B., Taylor, D. G., & Richmond, J. Y. (2002). Biosafety considerations for autopsy. The American Journal of Forensic Medicine and Pathology, 23(2), 107-22.
Nolte KB, Taylor DG, Richmond JY. Biosafety Considerations for Autopsy. Am J Forensic Med Pathol. 2002;23(2):107-22. PubMed PMID: 12040252.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Biosafety considerations for autopsy.
AU - Nolte,Kurt B,
AU - Taylor,David G,
AU - Richmond,Jonathan Y,
PY - 2002/6/1/pubmed
PY - 2002/7/27/medline
PY - 2002/6/1/entrez
SP - 107
EP - 22
JF - The American journal of forensic medicine and pathology
JO - Am J Forensic Med Pathol
VL - 23
IS - 2
N2 - An autopsy may subject prosectors and others to a wide variety of infectious agents, including bloodborne and aerosolized pathogens such as human immunodeficiency virus, hepatitis B and C viruses, and Mycobacterium tuberculosis. Other hazards include toxic chemicals (e.g., formalin, cyanide, and organophosphates) and radiation from radionuclides used for patient therapy and diagnosis. These risks can be substantially mitigated through proper assessment, personal protective equipment, appropriate autopsy procedures, and facility design.
SN - 0195-7910
UR - https://www.unboundmedicine.com/medline/citation/12040252/Biosafety_considerations_for_autopsy_
L2 - https://doi.org/10.1097/00000433-200206000-00001
DB - PRIME
DP - Unbound Medicine
ER -